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Abstract
With the implementation of the Affordable Care Act (ACA), access to insurance and coverage of preventive care 
services has been expanded. By removing the barrier of shared costs for preventive care, it is expected that an increase 
in utilization of preventive care services will reduce the cost of chronic diseases. Early detection and treatment is 
anticipated to be less costly than treatment at full onset of chronic conditions. One concern of early detection of 
disease is the cost to treat.  In reality, the confluence of early detection may result in greater overall expenditures. Even 
with improved access to preventive care benefits, cost-sharing of other health services remains a major component 
of insurance plans. In order to treat identified conditions or diseases, cost-sharing comes into play. With the 
greater adoption of cost-sharing insurance plans, expenditures on the part of enrollee are anticipated to rise. Once 
the healthcare recipients realize the implication of early identification and resultant treatment costs, enrollment in 
preventive care may decline. Healthcare legislation and regulation should consider the full spectrum of care and the 
microeconomic costs associated with preventive treatment. Although the system at large may not realize the immediate 
impact, behavioral shifts on the part of healthcare consumers may alter healthcare. Rather than the current status quo 
of treating presenting conditions, preventive treatment is largely anticipated to require more resources and may impact 
the consumer’s financial capacity. This report will explore how these two concepts are co-dependent, and highlight the 
need for continued reform.
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Statement of the issue and background
The need for healthcare access and cost management of 
healthcare programs is essential for a healthy community 
and sustainable health system. Various approaches have been 
attempted in the past several decades with varying degrees of 
success. Health reform is a continuous process. For the United 
States, the largest previous success in healthcare reform was 
the implementation of Medicare and Medicaid. Since that 
time, it has been apparent that high costs and suboptimal 
quality outcomes require further attention. Growing interest in 
healthcare reform culminated in the passage of the Affordable 
Care Act (ACA) of 2010. The Kaiser Family Foundation has 
put together a summary of the Patient Protection and ACA 
(1).  The aim of this program is to provide access to affordable 
health insurance, and by extension, quality healthcare to all 
Americans. This act required legislation regarding access to 
health insurance, preventive care coverage, and efficiency of 
healthcare. Insurance providers are required to cover certain 
preventive care procedures without additional costs such as 
copay or coinsurance to the beneficiary. On the other hand, 
the insured patient has shared cost responsibilities related to 
non-preventive services that may be recommended as part 
of a preventive care visit. Shared costs are viewed in part as 
a technique to control costs associated with overutilization 
of healthcare services. There are a number of informational 
resources available for healthcare consumers to learn about 
covered preventive care (2,3). The ACA now provides 
expanded access to insurance coverage for preventive and 
treatment strategies to previously uninsured (4). The ACA 
takes on a monumental effort to address quality of care, health 
outcomes, and cost of care. By providing greater access to 
healthcare through increased numbers of insured enrollees, 
a cost shift is expected to take place. According to the recent 
health system reform legislation, insurance beneficiaries are 
entitled to preventive care procedures that are recommended 
by the U.S. Preventive Services Task Force without cost-
sharing (2,5,6). There are limitations to coverage without 
cost-sharing for these preventive care procedures, including 
but not limited to: enrollment in a participating health plan, 
meeting certain restriction criteria such as risk factors and 
gender (2,3). A listing of the current recommendations by 
the U.S. Preventive Services Task Force is available on the 
their website (7). The 45 recommended preventive services 
are required to be covered, as well as annual visits and the 
recommended prevented services covered by Medicare (5). 
Cost-sharing is a two-prong approach to instill personal 
responsibility for healthcare while controlling spending (8). 
However, concerns arise to the coverage and cost-sharing 
associated with addressing issues that arise due to preventive 
care. Non-preventive care services are not without cost-
sharing, and therefore may result in elevated immediate costs 
to the patient. These non-preventive care costs may include 
ancillary tests or follow-up visits to interrogate abnormal 
results from preventive care visits.
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Current situation
Coverage of preventive care services aims to reduce the 
amount of undiagnosed or untreated conditions. This is 
expected to reduce costs through less invasive or complex 
treatment options. Cost-sharing of supplemental tests, 
procedures, and follow-up visits as a result of preventive 
care are subject to insurance deductibles or co-pays 
(9). The insured is then responsible for the cost of non-
preventive services. Overhauls of the healthcare system 
include changes to integrated delivery networks such as 
accountable care organizations or long-term care facilities. 
These changes are aimed at reducing medical costs through 
improved coordination and integration of care along with 
lowering re-admissions and healthcare acquired infections 
(4). These efforts are much needed, yet the impact of cost 
reduction remains to be determined. Furthermore, it is 
unclear how these cost reductions will be passed on to the 
patient receiving care. In addition, the assumption that the 
overall cost reduction from identifying underlying conditions 
through early intervention via preventive care visits may be 
flawed. The system costs may in fact be reduced but it is likely 
that the patient will incur early prevention costs associated 
with wellness efforts, medication, prophylaxis or follow-up 
examinations. Under the ACA, cost-sharing for basic health 
coverage is based on income (4). Without transparency 
of costs, overhead and efficiency in delivery of care, it is 
improbable for an average worker to afford treatment costs 
of a major episode. It has been reported that medical debt is a 
point of cause in up to 62% of bankruptcy cases (9). Of these 
bankruptcy cases, 75% of the debtors had health insurance 
(9). This points to a need for cost control and patient financial 
liability protection through acquired health insurance. Out-
of-Pocket (OOP) medical expenses can average 22,568 US 
dollars for a family (9). A recent report revisited this issue 
following Massachusetts’ health reform which successfully 
provided insurance to previously uninsured. Unfortunately, 
the study did not reveal a decrease in the rate of medical 
bankruptcy following reform (10). Simply reducing the 
number of uninsured people does not result in financial 
solvency protection. Bankruptcy due to medical costs 
reflects the financial liability assumed from seeking medical 
intervention for diagnosis or treatment of illness. A number 
of factors affect the ability of the patient to pay including 
income resources, insurance coverage of care costs, and the 
cost of care. Healthcare costs remain high and annual medical 
expenses in excess of 20,000 US dollars are beyond the average 
family’s financial capacity (11).
Options analysis 
Many insurance companies seek to shift the financial 
responsibility to the consumer in order to avoid increasing 
health related costs (12). Even with ACA maximum limits 
on OOP expenses, bankruptcy remains a threat until this 
maximum level is brought to a manageable figure. The ACA 
protects consumers from catastrophic consequences of 
medical care. However, those in the private healthcare system 
face significant medical expenses when frequent visits are 
required to treat chronic conditions. The issue of preventive 
care services utilization has drawn much focus in identifying 
the benefits of such medical care. In general, it is accepted that 
services which save more money than the cost of delivering 
said service are of benefit. Examples include health 
assessments, immunizations, and preventive consultations 
(13). A broader definition of beneficial preventive services 
suggests that prevention must only result in a health benefit 
(13). Perhaps this is where the misinformation occurs. 
Prevention does not necessarily reduce medical costs as a rule, 
although there may be examples where cost savings occur 
(14). In fact, prevention costs can exceed the amount saved. 
There are a number of preventive services that directly reduce 
costs and include childhood immunizations, risky behavior 
counseling (e.g. smoking cessation, illicit drug abstinence), 
cardiovascular prophylaxis such as daily aspirin, and certain 
cancer screens (13). By coordinating preventive services 
with lifestyle changes improved public health is expected. 
The benefit is longer and potentially more productive lives 
attributed to preventive care. In order to achieve higher 
efficacy and therefore return on investment in preventive 
care, those services with minimal evidence of effectiveness 
should be held to an assessment process (13). This strategy 
will help preserve healthcare dollars for those procedures 
with known benefit. A downside is that emerging strategies 
or procedures are unable to present historical information 
to their potential benefit. This would become a prohibitive 
barrier to those treatments which would otherwise have a 
positive impact on healthcare.  
Outside of strictly medical facilities exist additional 
opportunities to positively influence population health. 
Wellness strategies that rely on employers to provide wellness 
programs can encourage healthy lifestyle behaviors (15). 
In efforts to address concerns related to rising healthcare 
costs, employers are deploying strategies aimed at reducing 
employee absenteeism while improving production and 
corporate morale (15). These programs address individual 
behaviors including physical activity, exercise, weight loss, 
and smoking cessation (15). Potential hurdles companies 
will face include ethical, legal, and practical aspects of 
mandating employee participation and adherence to wellness 
initiatives (15). Employees may potentially feel manipulated 
into participating in the wellness program. Additionally, 
chronically ill employees may feel a burden of embarrassment 
or penalized by not being able to reap the benefits of a reward 
system. Other unintended consequences include the time 
constraints of busy professionals balancing work and family 
life and thus, are unable to participate in a corporate fitness 
program. Of course, the benefit to wellness programs and 
initiatives are the anticipated gains in employee productivity, 
reduced stress, happiness, emotional well-being, and overall 
lowered health related expenses. In order to avoid legal 
sanctions, employers should seek to avoid unintentional 
discrimination in these programs for protected groups. 
Appropriate alternatives should be available. Furthermore, 
taking action to deploy a wellness program demonstrates the 
willingness and character of the company to develop healthy 
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and productive staff.   
The goal of cost-sharing is to shift patient behavior into a 
consumer mind-set focused on deriving the best value for 
the dollar. This approach is termed value-based cost-sharing 
(16). In healthcare, value-based cost-sharing occurs when 
the patient seeks treatments, medications, procedures, and 
other services that yield the highest value compared with 
other options. In general, this has been largely applied to 
medications (16).  Preferred providers or preventive services 
can result in lower payments on the part of the insurance 
beneficiary. Cost-sharing is one piece of a value-based formula 
in reshaping healthcare. In contrast, cost-sharing may reduce 
health due to consumer choices to avoid costly medication 
which has a negative impact (16). A further complication 
is the difficulty in determining what constitutes high-value 
care. The definition of value is interpreted differently among 
different people. Administrative costs for determining value 
are prohibitively high due to the complexities associated 
with evaluating healthcare costs (16). The need for careful 
policy development to avoid pitfalls of patient cost-sharing is 
imperative for effective performance and quality outcomes. 
Finally, even good values should be affordable to the patient. 
This leads to the need for overall reduction in costs and 
translating those cost reductions into affordable prices for 
the patient’s cost share.
Discussion and recommendation 
Savings related to preventive care extend beyond the 
immediate effect into future benefits, particularly for 
vaccinations (14). Preventive care options should be modeled 
after those procedures which have a cost which is lower 
than the potential treatment cost. Cost-sharing is a major 
component of current insurance programs, yet the incurred 
cost of care for a chronic or major acute condition is greater 
than the financial capacity of the average American family. 
Despite the maximum OOP limit imposed by the ACA, 
there remains a great deal to be done in order to offset these 
costs. Cost reduction for healthcare is essential. In addition, 
insurance providers need to assume a greater bulk of the 
cost of care. Healthcare reform requires continuous process 
improvements in access of care, quality, and cost control 
(17).  While the ACA does much to address cost control at 
the institutional level, it remains unclear how these controls 
result in a reduction of cost at the individual patient level. 
More transparency of costs in addition to cost savings 
for those undergoing preventive treatments is necessary 
for successful execution of the preventive care strategy. 
Compliance with treatment regimens is strongly influenced 
by patient education as well as economical and affordable 
solutions. To that end, cost reduction is essential in order to 
reduce the patient’s financial responsibility. Cost management 
remains a popular topic among care providers, insurers, and 
prospective patients. Effective cost-sharing enables a number 
of fully covered preventive care options to the prospective 
patient while avoiding barriers to essential care. The result 
can be reduced specialists visits without negatively impacting 
primary care visits (18). Cost-sharing has demonstrated 
effectiveness in managing healthcare costs for insurers. In 
order to reach the desired level of healthcare utilization and 
optimal outcomes, a balance between fully covered (no OOP 
cost) preventive care, cost-sharing, and maximum OOP 
limits for patients is essential. The ACA has the infrastructure 
in place to address these issues, but further refinement 
is likely necessary. Furthermore, education of insurance 
beneficiaries on cost-sharing exempt preventive care services 
will prevent these patients from avoiding care due to concerns 
over cost (19). There remains confusion related to the cost 
of services resulting in delays of care even when the cost is 
free or minimal.  Removing barriers related to cost concerns, 
including education regarding coverage, is essential for 
early intervention of both acute and chronic illnesses. By 
removing even small cost barriers such as copays and OOP 
expenses for major preventive care services, the ACA has 
taken steps to identify treatment for improved health (20). It 
is widely evident that the U.S. has the best resources available 
for healthcare.  
Conclusions
Rather than stymieing the adoption of solutions related 
to preventive costs and cost-sharing, it is incumbent that 
the U.S. society embrace the overarching aim to improve 
national health quality. There are a number of dilemmas and 
challenges associated with formulating a program that has 
the perfect solution to every combination of circumstances. 
Notwithstanding those challenges, it remains to be seen how 
the next iteration should be unfolded to address healthcare 
reform. It is evident that an optimal combination of covered 
preventive care services, cost-sharing, and cost reductions 
are needed to improve quality and access to care. In the 
interim, policy officials, healthcare payers, and healthcare 
professionals should synergize their efforts to provide high 
quality healthcare at the lowest cost to all those in need of 
care.  Ongoing improvements will remain essential in the 
endeavor to deliver high quality, affordable healthcare to 
all Americans. Clearly, the need to increase access to these 
valuable resources has the potential to have a major impact 
on healthcare and wellness. The benefits of reaching the noble 
goal of healthcare access and affordability serve both present 
and future generations. Navigating the challenges presented 
to provide broad access to health resources is surmountable 
given the available intellectual capacity. A patient centric 
focus is imperative when formulating reformation solutions. 
Maintaining the perspective of patient first will serve as a 
foundation for both quality and cost concerns.  
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